193 related articles for article (PubMed ID: 21309118)
21. Changes in rat serum corticosterone after treatment with metabotropic glutamate receptor agonists or antagonists.
Johnson MP; Kelly G; Chamberlain M
J Neuroendocrinol; 2001 Aug; 13(8):670-7. PubMed ID: 11489083
[TBL] [Abstract][Full Text] [Related]
22. [3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells.
Johnson BG; Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
Neuropharmacology; 1999 Oct; 38(10):1519-29. PubMed ID: 10530814
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article.
Kuhn R; Pagano A; Stoehr N; Vranesic I; Flor PJ; Lingenhöhl K; Spooren W; Gentsch C; Vassout A; Pilc A; Gasparini F
Amino Acids; 2002; 23(1-3):207-11. PubMed ID: 12373539
[TBL] [Abstract][Full Text] [Related]
24. Biochemical and electrophysiological studies on (S)-(+)-2-(3'-carboxybicyclo(1.1.1)pentyl)-glycine (CBPG), a novel mGlu5 receptor agonist endowed with mGlu1 receptor antagonist activity.
Mannaioni G; Attucci S; Missanelli A; Pellicciari R; Corradetti R; Moroni F
Neuropharmacology; 1999 Jul; 38(7):917-26. PubMed ID: 10428410
[TBL] [Abstract][Full Text] [Related]
25. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
Palucha A; Pilc A
Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
[TBL] [Abstract][Full Text] [Related]
26. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.
Linden AM; Shannon H; Baez M; Yu JL; Koester A; Schoepp DD
Psychopharmacology (Berl); 2005 Apr; 179(1):284-91. PubMed ID: 15619115
[TBL] [Abstract][Full Text] [Related]
27. Group II and group III metabotropic glutamate receptor agonists depress synaptic transmission in the rat spinal cord dorsal horn.
Gerber G; Zhong J; Youn D; Randic M
Neuroscience; 2000; 100(2):393-406. PubMed ID: 11008177
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationships for negative allosteric mGluR5 modulators.
Kaae BH; Harpsøe K; Kvist T; Mathiesen JM; Mølck C; Gloriam D; Jimenez HN; Uberti MA; Nielsen SM; Nielsen B; Bräuner-Osborne H; Sauerberg P; Clausen RP; Madsen U
ChemMedChem; 2012 Mar; 7(3):440-51. PubMed ID: 22267204
[TBL] [Abstract][Full Text] [Related]
29. Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs.
Wierońska JM; Pilc A
Neurochem Int; 2009; 55(1-3):85-97. PubMed ID: 19428811
[TBL] [Abstract][Full Text] [Related]
30. Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders.
Spooren WP; Gasparini F; Salt TE; Kuhn R
Trends Pharmacol Sci; 2001 Jul; 22(7):331-7. PubMed ID: 11431019
[TBL] [Abstract][Full Text] [Related]
31. Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.
Mercier MS; Lodge D
Neurochem Res; 2014 Oct; 39(10):1876-94. PubMed ID: 25146900
[TBL] [Abstract][Full Text] [Related]
32. Metabotropic glutamate receptors: beyond the regulation of synaptic transmission.
Nicoletti F; Battaglia G; Storto M; Ngomba RT; Iacovelli L; Arcella A; Gradini R; Sale P; Rampello L; De Vita T; Di Marco R; Melchiorri D; Bruno V
Psychoneuroendocrinology; 2007 Aug; 32 Suppl 1():S40-5. PubMed ID: 17651904
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
34. Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illness.
Lesage A; Steckler T
Eur J Pharmacol; 2010 Aug; 639(1-3):2-16. PubMed ID: 20371230
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents.
Engers JL; Rodriguez AL; Konkol LC; Morrison RD; Thompson AD; Byers FW; Blobaum AL; Chang S; Venable DF; Loch MT; Niswender CM; Daniels JS; Jones CK; Conn PJ; Lindsley CW; Emmitte KA
J Med Chem; 2015 Sep; 58(18):7485-500. PubMed ID: 26335039
[TBL] [Abstract][Full Text] [Related]
36. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
[TBL] [Abstract][Full Text] [Related]
37. mGlu receptors as potential targets for novel antidepressants.
Chaki S; Fukumoto K
Curr Opin Pharmacol; 2018 Feb; 38():24-30. PubMed ID: 29486373
[TBL] [Abstract][Full Text] [Related]
38. Psychiatric drugs. Excited by glutamate.
Holden C
Science; 2003 Jun; 300(5627):1866-8. PubMed ID: 12817119
[No Abstract] [Full Text] [Related]
39. Endogenous sulphur-containing amino acids: potent agonists at presynaptic metabotropic glutamate autoreceptors in the rat central nervous system.
Croucher MJ; Thomas LS; Ahmadi H; Lawrence V; Harris JR
Br J Pharmacol; 2001 Jul; 133(6):815-24. PubMed ID: 11454654
[TBL] [Abstract][Full Text] [Related]
40. LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.
Kingston AE; Ornstein PL; Wright RA; Johnson BG; Mayne NG; Burnett JP; Belagaje R; Wu S; Schoepp DD
Neuropharmacology; 1998; 37(1):1-12. PubMed ID: 9680254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
